MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 234 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q1 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,302,651 | +40.9% | 265,700 | +58.8% | 0.01% | 0.0% |
| Q1 2023 | $2,343,887 | +242.4% | 167,301 | +249.8% | 0.01% | +233.3% |
| Q4 2022 | $684,505 | -4.9% | 47,834 | +134.2% | 0.00% | 0.0% |
| Q1 2022 | $720,000 | -71.9% | 20,428 | -66.6% | 0.00% | -57.1% |
| Q4 2021 | $2,562,000 | -67.0% | 61,153 | -67.1% | 0.01% | -76.7% |
| Q2 2021 | $7,764,000 | +43.3% | 186,062 | +22.4% | 0.03% | -6.2% |
| Q1 2021 | $5,417,000 | -36.6% | 152,000 | -50.1% | 0.03% | -50.0% |
| Q4 2020 | $8,541,000 | – | 304,479 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $1,064,105,000 | 26.99% |
| Ghisallo Capital Management LLC | 1,250,000 | $61,350,000 | 2.33% |
| Beck Bode, LLC | 160,064 | $7,856,000 | 2.19% |
| Select Equity Group, L.P. | 12,122,011 | $594,948,300,000 | 2.00% |
| Pinz Capital Management, LP | 83,603 | $4,103,000 | 1.86% |
| Monashee Investment Management LLC | 185,000 | $9,080,000 | 1.68% |
| Ownership Capital B.V. | 2,717,559 | $133,378,000 | 1.51% |
| Eversept Partners, LP | 327,810 | $16,088,915 | 1.12% |
| Parkman Healthcare Partners LLC | 90,000 | $4,417,000 | 1.12% |
| Connacht Asset Management LP | 28,569 | $1,402,000 | 0.91% |